Spelling suggestions: "subject:"embrane transporters"" "subject:"5membrane transporters""
1 |
Contribution of Membrane Transporters to the Disposition of Organic CationsUddin, Muhammad Erfan 15 September 2022 (has links)
No description available.
|
2 |
Coordinated Regulation Of Hepatic And Renal Membrane Transporters In Experimental Nonalcoholic SteatohepatitisJimenez-Canet, Mark January 2014 (has links)
Inter-individual variability in drug response is a significant clinical concern and may lead to the development of adverse drug reactions, which are currently a top-ten cause of death in the United States. Recently, the manifestation of disease, which may alter normal physiological function, has gained increased attention for its role as a contributing factor in the development of inter-individual responses to drugs. One such disease, known as nonalcoholic fatty liver disease (NAFLD), is the most common chronic liver disease in Western society and represents a spectrum of clinical morbidities that range from the usually benign simple fatty liver to the more advanced nonalcoholic steatohepatitis (NASH). Prior investigations have identified liver-specific alterations in xenobiotic transporter and metabolizing enzymes in NASH, which lead to the functional disruption of drug disposition. To identify a useful model(s) that is representative of hepatic transporter expression profiles in humans with NASH, gene and protein expression profiles of liver membrane transporters were assayed across several commonly used experimental rodent models of the disease. NASH models that were representative of the human condition developed global, adaptive changes in transporter regulation in the liver, which was not present in models that failed to recapitulate human profiles. Specifically, decreased expression of hepatic uptake transporters was coupled with an induction of efflux transporters, which may serve as a hepatoprotective response by limiting hepatic exposure to potentially harmful substances during times of tissue stress. To link a possible molecular mechanism for these hepatic adaptations in NASH, the role of the oxidative stress-activated transcription factor, Nrf2, was investigated. A functional Nrf2 regulatory element was identified within the eighth intron of the human ABCC3 transporter gene, implicating Nrf2 activation in NASH as a contributor to the coordinated induction of hepatic efflux transporters in the disease. To further clarify the effects of NASH on renal membrane transporter regulation, a thorough analysis of gene and protein expression was conducted with the validated rodent models used previously. Following the manifestation of disease, a global induction of renal efflux was observed, suggesting a compensatory, coordinated response of membrane transporters in the kidney upon disease induction. The functional consequences of liver and kidney xenobiotic transporter dysregulation was shown to disrupt the disposition of the environmental toxicant, arsenic. Specifically, NASH results in increased excretion of arsenic into urine as well as altered hepatic and renal exposure. These findings are associated with hepatic and renal transporter dysregulation and demonstrate for the first time that NASH alters the disposition of environmental toxicants. In summary, these studies contribute novel findings that identify liver and kidney-specific adaptations in disease that may contribute to global alterations in xenobiotic disposition thereby increasing the likelihood of developing adverse drug reactions in patients with NASH.
|
3 |
Zapojení přenašečů AtKT/HAK/KUP v příjmu K+ a Cs+ rostlinami / Involvement of AtKT/HAK/KUP high-affinity transporters in plant K+ and Cs+ uptakeŠustr, Marek January 2015 (has links)
Potassium is essential macroelement and large amount of potassium is taken up by plants, because it's the major osmotic of plant cell. Due to various potassium availability in different kinds of soil, plants have evolved transport system that can maintain sufficient K+ uptake between several orders of magnitude of potassium concentration. In Arabidopsis thaliana mechanism of K+ acquisition is well understood and it's known that AtHAK5 is mainly involved in K+ uptake in its very low concentrations. AtHAK5 belongs to KT/HAK/KUP family that consist 13 members in A. thaliana. There's known function for some members for example in auxin transport in root tip (TRH1) or in K+ efflux in stomatal closure (KUP6). In this thesis possible involvement of yet unstudied transporters KUP5, KUP7, KUP9 and KUP10 in K+ acquisition and homeostasis in A. thaliana was investigated. In vitro cultivation showed that kup9 mutant has very short lateral roots in K+ deficiency. On the other hand kup5 mutant showed significantly higher dry weight in K+ deficiency than Col-0. Kup9 phenotype was successfully replicated in subsequent cultivations and anatomy of lateral root apical meristems was investigated. Root tips of kup9 were differently organized in K+ deficiency and they showed signs of early termination of meristems. To...
|
4 |
Interactions de la fumée de cigarette et ses composés avec les transporteurs membranaires dans des modèles hépatiques et non-hépatiques / Interactions of cigarette smoke and its contained components with drug transporters in hepatic and non-hepatic cell modelsSayyed, Katia 29 October 2018 (has links)
La fumée de cigarette peut endommager plusieurs organes de notre organisme, causant des maladies chroniques sévères et divers types de cancers. Elle interagit notamment avec les enzymes de métabolisme des médicaments de phase I et II, et contribue ainsi à la perturbation de la pharmacocinétique de divers médicaments chez les fumeurs. Les transporteurs membranaires sont des acteurs majeurs de l'absorption, la distribution et l'élimination de médicaments, et certains sont impliqués dans les interactions médicamenteuses. De plus, ils assurent le flux des molécules endogènes physiologiques vitales, et l'élimination de divers xénobiotiques toxiques non seulement chez les mammifères mais aussi chez les êtres unicellulaires, comme les levures. Ces transporteurs sont des cibles potentielles de la fumée de cigarette. D’où l'importance d'étudier l'interaction de la fumée de cigarette et de ses composés avec les transporteurs membranaires. Nos résultats démontrent que le condensat de fumée de cigarette (CSC) modifie l'activité fonctionnelle et/ou l'expression de plusieurs transporteurs hépatiques et rénaux in vitro dans des modèles cellulaires hépatiques et/ou non-hépatiques, notamment les OATPs (organic anion transporting polypeptide), l'OCT1 (organic cation transporter 1), la BCRP (breast cancer resistance protein) et l'OAT3 (organic anion transporter 3). Une implication remarquable du récepteur Ah (AhR) est mise en évidence dans la régulation de l'expression de certains transporteurs comme la MRP4 (multidrug resistance-associated protein), la BCRP, l'OAT2 et l'OCT1 dans des cellules HepaRG exposées au CSC. De plus, chez la levure Saccharomyces cerevisiae, le CSC inhibe l'activité d'efflux notamment des transporteurs de la rhodamine 123 et de la caféine, et induit, après trois heures, leur expression avec d'autres gènes qui sont aussi impliqués dans la résistance aux xénobiotiques comme les transporteurs de la membrane plasmique le Pdr5, le Snq2, le Pdr10, le Pdr15 et le Tpo1. Enfin, un effet inhibiteur remarquable des amines aromatiques hétérocycliques (AAH) est mis en évidence in vitro, notamment celui de Trp-P-1 et de Trp-P2 sur l'activité des transporteurs OCT1 et OCT2. De plus, les données in silico suggèrent que des descripteurs moléculaires des AAH comme l'AMW (average molecular weight), la qnmax (maximum negative charge) et le SPP (submolecular molarity parameter), sont des paramètres cruciaux de l'inhibition commune des OCT1, OCT2 et OCT3 par les AAH. Le CSC est donc un modulateur bifonctionnel, qui peut intervenir dans la régulation de l'activité et de l'expression des transporteurs membranaires hépatiques et rénaux, ainsi que ceux chez la levure. De telles interactions peuvent contribuer à l'altération de la pharmacocinétique des médicaments et des composés endogènes chez les fumeurs, d’où l'évaluation de l'exposition hépatique et rénale au CSC demeure indispensable. / Cigarette smoke can damage every part of our body, causing severe chronic diseases and various types of cancers. It also interacts with drug metabolizing enzymes of phase I and II, and thus contributes to pharmacokinetics disruption of various drugs in smokers. Membrane drug transporters are major actors involved in drugs absorption, distribution and elimination, and some are involved in drug-drug interactions. In addition, membrane drug transporters ensure the flow of vital physiological endogenous molecules, and the elimination of various toxic xenobiotics, not only in mammals but also in unicellular organisms, especially in yeasts. Therefore, this indicates the importance of studying the interaction of cigarette smoke and its contained chemicals with drug transporters. Our results demonstrate that cigarette smoke condensate (CSC) modifies the functional activity and / or expression of several hepatic and renal transporters in vitro in hepatic and / or non-hepatic cellular models, including OATPs (organic anion transporting polypeptide), OCT1 (organic cation transporter 1), BCRP (breast cancer resistance protein) and OAT3 (organic anion transporter 3). A remarkable implication of Ah receptor (AhR) was also demonstrated in MRP4 (multidrug resistance-associated protein), BCRP, OAT2 and OCT1 expression regulation in HepaRG cells exposed to CSC. In addition, in Saccharomyces cerevisiae, CSC inhibits the efflux activity of at least the rhodamine 123 and caffeine transporters, and induces, after three hours, their expression and that of others involved in xenobiotic resistance such as plasma membrane transporters Pdr5, Snq2, Pdr10, Pdr15 and Tpo1. Finally, a remarkable inhibitory effect of heterocyclic aromatic amines (HAA) is demonstrated in vitro, in particular that of Trp-P-1 and Trp-P-2 on the activity of OCT1 and OCT2. In addition, in silico data suggest that molecular descriptors of HAA such as AMW (average molecular weight), qnmax (maximum negative charge) and SPP (submolecular molarity parameter), may represent crucial parameters for common inhibition of OCT1, OCT2 and OCT3 transporters by HAA. Thus, CSC acts as bifunctional modulator, which can regulate activity and expression of hepatic and renal drug transporters as well as some membrane transporters in yeasts. Such interactions may contribute to the alteration of the pharmacokinetics of drugs and endogenous compounds in smokers, hence the evaluation of hepatic and renal exposure to CSC remains essential.
|
5 |
Régulation de l'expression fonctionnelle de transporteurs membranaires dans des cellules hépatocytaires et pulmonaires exposées aux extraits de particules diesel / Regulation of the functional expression of membrane transporters in hepatocytic and lung cells exposed to extracts of diesel particulatesLe Vée, Marc 09 December 2015 (has links)
Les transporteurs membranaires jouent un rôle primordial dans la pharmacocinétique de médicaments mais aussi dans le transport de composés endogènes. La maîtrise de modèle in vitro permettant d’évaluer leur implication dans des interactions médicamenteuses, notamment au niveau hépatique, est donc primordiale. L’utilisation de ces modèles permettra aussi de déterminer l’impact potentiel de contaminants environnementaux, comme les particules diesel, sur l’expression fonctionnelle de transporteurs. Nos résultats démontrent la fiabilité de modèles hépatocytaires (hépatocytes et cellules d’hépatome HepaRG) en culture monocouche pour l’étude du transport membranaire de médicaments. Grâce à ces modèles, nous avons mis en évidence que des extraits de particules diesel (DEPe) peuvent modifier l’expression et/ou la fonction de transporteurs membranaires hépatiques, les Organic Anion Polypeptide Transporter (OATP) et les Multidrug Resistance associated Protein (MRP). Au niveau pulmonaire, les DEPe peuvent aussi augmenter l’expression du complexe LAT1/CD98hc, un complexe protéique de transport d’acides aminés souvent associé à de mauvais pronostics dans les cas de cancer du poumon. En conclusion, nos résultats mettent en évidence que les DEPe peuvent intervenir dans la régulation de l’activité et de l’expression de transporteurs membranaires tant au niveau hépatique qu’au niveau pulmonaire. / Membrane transporters play a major role in the pharmacokinetic of drugs and in the transport of endogenous compounds. The development of in vitro models for the study of their expression and activity is therefore important to consider, notably for analyzing their interactions with drugs or environmental contaminants such as diesel exhaust particles. Our results demonstrated the reliability of hepatocytic cells (hepatocytes and highly differentiated hepatoma HepaRG cells) in monolayer culture for the study of membrane transport of drugs. Using these models allowed us to demonstrate that extracts of diesel exhaust particles (DEPe) can alter the expression and / or function of major liver transporters such as organic anion transporting polypeptides (OATP) and Protein Multidrug associated Resistance (MRP). In lung cells, DEPe can increase the expression of complex LAT1 / CD98hc a protein complex, that is associated with poor prognosis in lung cancer. In conclusion, our results demonstrated that DEPe can regulate activity and expression of membrane transporters at hepatic and lung level.
|
6 |
The role of membrane transporters in the pharmacokinetics of psychotropic drugs: in vitro studies with special focus on organic cation transportersSantos Pereira, João Nuno dos 30 January 2015 (has links)
No description available.
|
7 |
Fluorescent Visualization of Cellular Proton FluxesZhang, Lejie 06 September 2018 (has links)
Proton fluxes through plasma membranes are essential for regulating intracellular and extracellular pH and mediating co-transport of metabolites and ions. Although conventional electrical measurements are highly sensitive and precise for proton current detection, they provide limited specificity and spatial information. My thesis focuses on developing optical approaches to visualize proton fluxes from ion channels and transporters.
It has been demonstrated that channel-mediated acid extrusion causes proton depletion at the inner surface of the plasma membrane. Yet, proton dynamics at the extracellular microenvironment are still unclear. In Chapter II, we developed an optical approach to directly measure pH change in this nanodomain by covalently attaching small-molecule, fluorescent proton sensors to the cell’s glycocalyx using glyco-engineering and copper free ‘click’ chemistry. The extracellularly facing sensors enable real-time detection of proton accumulation and depletion at the plasma membrane, providing an indirect readout of channel and transporter activity that correlated with whole-cell proton current. Moreover, the proton wavefront emanating from one cell was readily visible as it crossed over nearby cells.
The transport of monocarboxylates, such as lactate and pyruvate is critical for energy metabolism and is mainly mediated by proton-coupled monocarboxylate transporters (MCT1-MCT4). Although pH electrodes and intracellular fluorescent pH sensors have been widely used for measuring the transport of proton-coupled MCTs, they are unable to monitor the subcellular activities and may underestimate the transport rate due to cell’s volume and intracellular buffering. In Chapter III, we used the Chapter II approach to visualize proton-coupled transport by MCT1-transfected HEK293T cells and observed proton depletion followed by a recovery upon extracellular perfusion of L-lactate or pyruvate. In addition, we identified a putative MCT, CG11665/Hrm that is essential for autophagy during cell death in Drosophila. The results demonstrate that Hrm is a bona fide proton-coupled monocarboxylate transporter that transports pyruvate faster than lactate.
Although the approach developed in Chapter II enables visualization of proton fluxes from ion channels and transporters, it’s not applicable in some cell types which cannot incorporate unnatural sialic acid precursors into their glycocalyx, such as INS-1 cells and cardiomyocytes. To address this, in Chapter IV we developed a pH-sensitive, fluorescent WGA conjugate, WGA-pHRho that binds to endogenous glycocalyx. Compared to the results in Chapter II and III, cell surface-attached WGA-pHRho has similar fluorescent signals in response to proton fluxes from proton channel Hv1, omega mutant Shaker-IR R362H and MCT1. With WGA-pHRho, we were able to label the plasma membrane of INS-cells and cardiomyocytes and visualized the transport activity of MCT1 in these cells.
Taken together, these findings provide news insights into proton dynamics at the extracellular environment and provide new optical tools to visualize proton fluxes from ion channels and transporters. Moreover, the modularity of the approaches makes them adaptable to study any transport events at the plasma membrane in cells, tissues, and organisms.
|
8 |
Développement et validation de méthodes de dosage du midazolam, un marqueur de l'activité des CYP3A, et de la fexofénadine, un substrat de la glycoprotéine P, dans les milieux biologiquesStepanova, Tatiana January 2009 (has links)
Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal.
|
9 |
Développement et validation de méthodes de dosage du midazolam, un marqueur de l'activité des CYP3A, et de la fexofénadine, un substrat de la glycoprotéine P, dans les milieux biologiquesStepanova, Tatiana January 2009 (has links)
Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal
|
10 |
Mise en place d’un nouveau test de perméabilité membranaire à l’aide de la glycoprotéine-P reconstituée dans des protéoliposomesFlandrin, Aurore 08 1900 (has links)
Les membranes cellulaires jouent un rôle important dans l’absorption des médicaments et la distribution de ceux-ci dans le corps humain. Elles contiennent différents transporteurs membranaires qui sont responsables des profils pharmacocinétiques, d’innocuité et d’efficacité des xénobiotiques. Lors du développement d’un médicament, il s’avère donc indispensable, de prédire l’interaction des nouveaux composés avec les transporteurs présents dans l’organisme. Le but du projet de recherche est de créer un nouvel outil pour étudier le comportement de la glycoprotéine-P (P-gp), un transporteur membranaire responsable du rejet de nombreux composés, sur différents médicaments. Pour cela, un modèle non cellulaire est développé en utilisant des protéoliposomes : des liposomes dans lesquels des transporteurs sont incorporés.
La méthodologie consiste tout d’abord à produire, extraire et purifier la protéine d’intérêt à partir de deux systèmes d’expression : MDCK-MDR1 (cellules de chien transfectées avec le gène humain MDR1) et Pichia pastoris (levures) fin de déterminer les avantages et les limites de ces deux types cellulaires. Différentes méthodes de reconstitution dans des protéoliposomes ont ensuite été testées avec la P-gp obtenue. Puis, l’activité ATPasique de la P-gp reconstituée a été évaluée en présence de différents substrats.
Les protocoles de culture cellulaire, d’extraction et de purification des deux systèmes d’expression ont été implémentés avec succès au sein du laboratoire. Les résultats montrent que les rendements obtenus sont supérieurs avec les levures qu’avec les cellules de mammifère. En outre, Pichia pastoris offre les avantages d’être facile et rapide à cultiver et peu couteux. Les premiers résultats d’activité ATPasique obtenus avec la P-gp reconstituée en protéoliposomes étaient prometteurs mais n’ont pas été reproduits en raison de la dégradation de la protéine membranaire. Les prochaines études du projet porteront sur un autre transporteur membranaire de la famille ABC, BCRP, une protéine de plus petite taille qui devrait montrer une plus grande stabilité pour mener à bien les tests. / Cellular membranes play an important role in the absorption and distribution of drugs in the human body. They contain different membrane transporters, which are responsible for the pharmacokinetic properties of drugs, as well as the safety and efficiency of their diffusion. When developing a new drug, it is thus of utmost importance to study the way that it will interact with the transporters present within the body. The aim of this study was to evaluate a new tool for measuring permeability in order to understand the function and mecanisms of P-glycoprotein (P-gp). P-gp is a transporter that is responsible for the rejection of many different compounds found in various drugs. This study thus seeks to use proteoliposomes to develop non-cellular models of membrane permeability including efflux and uptake transporters. This novel model of permeability will be utilized to study the underlying mechanisms of membrane permeability to xenobiotics.
The human P-gp was produced, extracted and purified using two different expression systems: MDCK-MDR1 cells (Madin-Darby canine kidney cells transfected with the human MDR1 gene) and Pichia pastoris. Both expression systems were studied in order to compare the strengths and weaknesses of each system. We then tested different methods of reconstituting the P-gp into protéoliposomes. Finally, we measured the level of ATPase activity using different substrates.
The protocols of cell culture, extraction and purification of both expression systems were accomplished in a laboratory during this study. These results demonstrated that expressing P-gp using yeast was more effective than that of mammalian cells. Furthermore, working with Pichia pastoris offers multiple advantages: expressing P-gp was easier, faster and cheaper than working with mammalian cells. The first measurements of ATPase activity using reconstituted P-gp proteoliposomes were promising, however they proved difficult to reproduce due to the possible degradation of the membrane protein.Further studies in this project will look to evaluate another ABC membrane transporter, BCRP. This smaller protein should prove to be more stable than P-gp, facilitating experimentation.
|
Page generated in 0.0841 seconds